Last $63.58 USD
Change Today +0.37 / 0.59%
Volume 666.2K
As of 8:04 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

albemarle corp (ALB) Snapshot

Open
$63.40
Previous Close
$63.21
Day High
$63.86
Day Low
$63.20
52 Week High
07/15/14 - $76.28
52 Week Low
07/31/14 - $59.86
Market Cap
5.0B
Average Volume 10 Days
821.0K
EPS TTM
$5.31
Shares Outstanding
78.2M
EX-Date
09/11/14
P/E TM
12.0x
Dividend
$1.10
Dividend Yield
1.62%
Current Stock Chart for ALBEMARLE CORP (ALB)

albemarle corp (ALB) Related Businessweek News

No Related Businessweek News Found

albemarle corp (ALB) Details

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals. It provides brominated and mineral based flame retardants under the Saytex, Martinal, and Magnifin brands that are used in plastic enclosures for consumer electronics, printed circuit boards, wire and cable, electrical connectors, textiles, and foam insulation; and plastic and other additives, such as curatives, antioxidants, and stabilizers under the Ethacure and Ethanox brands. The company also offers refinery catalysts, including hydroprocessing catalysts, fluidized catalytic cracking catalysts, and additives; organometallic co-catalysts and metallocene components and co-catalysts; electronic materials, such as high purity metal organic products, as well as other products; and chemical catalysts used in the chemical industry, as well as provides single-site catalysts and Ziegler-Natta catalysts under the Advantage brand. In addition, the company provides elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon, and bromine fine chemicals used in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, paper manufacturing, water purification, beef and poultry processing, and various other industrial applications, as well as tertiary amines for surfactants, biocides, disinfectants, and sanitizers; and aluminum oxides for use in various refractory, ceramic and polishing applications. Further, it supplies fine chemistry products and performance chemicals for pharmaceutical and agricultural use, as well as provides custom manufacturing, research, and chemical scale-up services for companies. The company serves petroleum refining, consumer electronics, plastics/packaging, construction, automotive, lubricants, pharmaceuticals, crop protection, food safety, and custom chemistry service markets. Albemarle Corporation was founded in 1993 and is headquartered in Baton Rouge, Louisiana.

albemarle corp (ALB) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $800.0K
Chief Financial Officer, Chief Risk Officer a...
Total Annual Compensation: $443.8K
Senior Vice President and President of Perfor...
Total Annual Compensation: $315.0K
Senior Vice President and President of Cataly...
Total Annual Compensation: $106.6K
Senior Vice President, General Counsel of Cor...
Total Annual Compensation: $397.0K
Compensation as of Fiscal Year 2013.

albemarle corp (ALB) Key Developments

Albemarle Corporation Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014; Provides Earnings Guidance for the Third, Fourth Quarter and Full Year 2014 and Full Year 2015

Albemarle Corporation announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported net sales of $604,721,000 against $576,842,000 a year ago. Operating profit was $110,240,000 against $108,380,000 a year ago. Net income from continuing operations was $89,404,000 against $88,500,000 a year ago. Net income attributable to the parent company was $22,447,000 against $82,739,000 a year ago. Diluted earnings per share from continuing operations was $1.04 against $0.95 a year ago. EBITDA was $57,709,000 against $138,370,000 a year ago. Adjusted EBITDA was $144,688,000 against $130,161,000 a year ago. Adjusted net income attributable to parent company was $86,806,000 against $79,164,000 a year ago. Adjusted diluted earnings per share were $1.10 against $0.94 a year ago. CapEx was $23 million. For the six months, the company reported net sales of $1,204,564,000 against $1,163,439,000 a year ago. Operating profit was $188,163,000 against $220,763,000 a year ago. Net income from continuing operations was $155,408,000 against $176,181,000 a year ago. Net income attributable to the parent company was $79,030,000 against $166,726,000 a year ago. Diluted earnings per share from continuing operations was $1.77 against $1.87 a year ago. Capital expenditures were $46,670,000 against $103,168,000 a year ago. EBITDA was $163,320,000 against $279,024,000 a year ago. Adjusted EBITDA was $280,718,000 against $263,279,000 a year ago. Adjusted net income attributable to parent company was $165,247,000 against $160,019,000 a year ago. Adjusted diluted earnings per share were $2.08 against $1.84 a year ago. Cash flow from operations was approximately $295.1 million for the six months ended June 30, 2014, up 65% from the same period in 2013. Free cash flow was $253 million, triple the performance from 2013 on better working capital results. For the third quarter, the company expects earnings to be in between the levels that the company delivered in the first and second quarters of this year. For the fourth year, the company expects earnings results to be close to what the company delivered in the second quarter. For the full year 2014, the company expects capex to continue tracking toward prior guidance of $100 million to $125 million. For 2015, the company expects to generate over $500 million in free cash flow, a significant portion of that cash flow will be necessary to pay taxes due as a result of the structure of the deal.

Albemarle Corporation Presents at Jefferies 2014 Global Industrials Conference, Aug-13-2014 12:30 PM

Albemarle Corporation Presents at Jefferies 2014 Global Industrials Conference, Aug-13-2014 12:30 PM. Venue: Grand Hyatt, 109 E. 42nd St., New York, New York, United States. Speakers: Matthew K. Juneau, Senior Vice President and President of Performance Chemicals, Scott A. Tozier, Chief Financial Officer, Chief Risk Officer and Senior Vice President.

Albemarle Corporation Provides Earnings Guidance for the Second Quarter of 2014

Albemarle Corporation provided earnings guidance for the second quarter of 2014. For the quarter, the company expects to report earnings in the range of $86 million to $88 million, or $1.08 to $1.11 per share, excluding discontinued operations, special and non-operating pension and OPEB items, compared to $79.2 million, or $0.94 per share, excluding discontinued operations, for the second quarter of 2013. As previously announced, the company signed a definitive agreement to sell its antioxidants, ibuprofen and propofol businesses which are treated as discontinued operations. The sale to SI Group is subject to customary closing conditions and expected to close later in 2014. The company expects to report net sales, adjusted for discontinued operations, of approximately $605 million in the second quarter of 2014, up from net sales of approximately $577 million in the second quarter of 2013. The improvement in results compared to the second quarter of 2013 was primarily driven by stronger than expected FCC volumes and higher volumes and favorable mix within polymer catalysts, offsetting relatively weaker clear completion fluid results, related to customer specific order patterns.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALB:US $63.58 USD +0.37

ALB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ALB.
View Industry Companies
 

Industry Analysis

ALB

Industry Average

Valuation ALB Industry Range
No financial data is available for ALB.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALBEMARLE CORP, please visit www.albemarle.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.